ATE368660T1 - Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside - Google Patents

Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside

Info

Publication number
ATE368660T1
ATE368660T1 AT01203571T AT01203571T ATE368660T1 AT E368660 T1 ATE368660 T1 AT E368660T1 AT 01203571 T AT01203571 T AT 01203571T AT 01203571 T AT01203571 T AT 01203571T AT E368660 T1 ATE368660 T1 AT E368660T1
Authority
AT
Austria
Prior art keywords
enantiomerically pure
nucleosides
pure beta
dioxolane nucleosides
dioxolane
Prior art date
Application number
AT01203571T
Other languages
English (en)
Inventor
Chung K Chu
Raymond F Schinazi
Original Assignee
Univ Georgia Res Found
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia Res Found, Univ Emory filed Critical Univ Georgia Res Found
Application granted granted Critical
Publication of ATE368660T1 publication Critical patent/ATE368660T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01203571T 1990-12-05 1991-12-05 Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside ATE368660T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/622,762 US5179104A (en) 1990-12-05 1990-12-05 Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides

Publications (1)

Publication Number Publication Date
ATE368660T1 true ATE368660T1 (de) 2007-08-15

Family

ID=24495427

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01203571T ATE368660T1 (de) 1990-12-05 1991-12-05 Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside

Country Status (9)

Country Link
US (1) US5179104A (de)
EP (4) EP0562009A4 (de)
JP (3) JP3421335B2 (de)
AT (1) ATE368660T1 (de)
AU (2) AU9147591A (de)
CA (2) CA2590125A1 (de)
DE (1) DE69133576T2 (de)
ES (1) ES2291268T3 (de)
WO (1) WO1992010497A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903224B2 (en) 1988-04-11 2005-06-07 Biochem Pharma Inc. Substituted 1,3-oxathiolanes
US6350753B1 (en) * 1988-04-11 2002-02-26 Biochem Pharma Inc. 2-Substituted-4-substituted-1,3-dioxolanes and use thereof
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US6175008B1 (en) 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5914331A (en) * 1990-02-01 1999-06-22 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5827727A (en) * 1990-02-01 1998-10-27 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US6703396B1 (en) 1990-02-01 2004-03-09 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5925643A (en) 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
US20050192299A1 (en) * 1992-04-16 2005-09-01 Yung-Chi Cheng Method of treating or preventing hepatitis B virus
GB9226927D0 (en) * 1992-12-24 1993-02-17 Iaf Biochem Int Dideoxy nucleoside analogues
US20020120130A1 (en) * 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
WO1995007086A1 (en) * 1993-09-10 1995-03-16 Emory University Nucleosides with anti-hepatitis b virus activity
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
DK0831852T3 (da) * 1995-06-07 2007-03-19 Univ Emory Nukleosider med anti-hepatitis B-virusaktivitet
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
US6022876A (en) * 1996-11-15 2000-02-08 Yale University L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections
US5792773A (en) * 1996-11-15 1998-08-11 Yale University L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection
DE69823984T2 (de) * 1997-03-19 2005-05-12 University Of Georgia Research Foundation, Inc. Synthese, anti-hiv- und anti-hepatitis-b-virus-aktivitäten von 1,3-oxaselenolannukleosiden
ES2237189T3 (es) 1998-11-02 2005-07-16 Gilead Sciences, Inc. Terapia de combinacion para tratar virus de la hepatitis b.
EA004767B1 (ru) 1998-12-23 2004-08-26 Шайре Байокем Инк. Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
US6511983B1 (en) 1999-03-01 2003-01-28 Biochem Pharma Inc. Pharmaceutical combination of antiviral agents
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
US6566365B1 (en) 1999-11-04 2003-05-20 Biochem Pharma Inc. Method for the treatment of Flaviviridea viral infection using nucleoside analogues
US6436948B1 (en) 2000-03-03 2002-08-20 University Of Georgia Research Foundation Inc. Method for the treatment of psoriasis and genital warts
CN1503796B (zh) 2001-03-01 2012-07-04 三角药品公司 顺-ftc的多晶型物及其它晶型
CA2502625A1 (en) * 2002-12-09 2004-06-24 The University Of Georgia Research Foundation, Inc. Dioxolane thymine and combinations for use against resistant strains of hiv
SI1583542T1 (sl) * 2003-01-14 2008-12-31 Gilead Sciences Inc Sestavki in postopki za kombinacijsko antivirusnoterapijo
DE10335061B4 (de) * 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
WO2005074654A2 (en) * 2004-02-03 2005-08-18 Emory University Methods to manufacture 1,3-dioxolane nucleosides
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
WO2009052050A1 (en) * 2007-10-15 2009-04-23 Pharmasset, Inc. Dioxolane thymine phosphoramidates as anti-hiv agents
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
EP2376515A1 (de) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthese von purinnukleosiden
JP5596174B2 (ja) 2009-12-22 2014-09-24 株式会社ブリヂストン 改良されたビニル変性剤組成物および当該組成物の利用方法
CL2011000718A1 (es) 2010-03-31 2012-04-09 Gilead Pharmasset Llc Proceso para la preparacion de compuestos fosforados enantiomericos.
CN103351414B (zh) * 2013-06-19 2016-06-01 河南中烟工业有限责任公司 烟用保润剂1-o-羟乙基-d-吡喃甘露糖及其制备方法
CN105339388B (zh) 2013-07-12 2021-06-15 Emd密理博公司 确定利用活性炭从包含靶蛋白的样品去除病毒的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041449A (en) * 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
NZ228645A (en) * 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
GB9103544D0 (en) * 1991-02-20 1991-04-10 Alcan Int Ltd Coating powders

Also Published As

Publication number Publication date
US5179104A (en) 1993-01-12
DE69133576D1 (de) 2007-09-13
JP2001097973A (ja) 2001-04-10
AU1664097A (en) 1997-07-17
EP1164133A2 (de) 2001-12-19
ES2291268T3 (es) 2008-03-01
WO1992010497A1 (en) 1992-06-25
CA2099589A1 (en) 1992-06-06
JP3881165B2 (ja) 2007-02-14
JP2007008959A (ja) 2007-01-18
AU9147591A (en) 1992-07-08
DE69133576T2 (de) 2008-04-17
AU714646B2 (en) 2000-01-06
EP1693373A1 (de) 2006-08-23
EP1164133A3 (de) 2002-01-02
CA2099589C (en) 2007-08-21
EP1600448A2 (de) 2005-11-30
JPH07502973A (ja) 1995-03-30
JP3421335B2 (ja) 2003-06-30
EP1600448A3 (de) 2006-08-23
CA2590125A1 (en) 1992-06-25
EP0562009A1 (de) 1993-09-29
EP0562009A4 (en) 1993-11-24
JP4280276B2 (ja) 2009-06-17
EP1164133B1 (de) 2007-08-01

Similar Documents

Publication Publication Date Title
ATE368660T1 (de) Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside
DE3880438D1 (de) Verfahren zur herstellung von aktivkohle.
DE3575050D1 (de) Verfahren zur herstellung einer monolitisch-integrierten, optischen schaltung enthaltend einen laser und eine nach diesem verfahren erhaltene schaltung.
DE68907783D1 (de) Verfahren zur herstellung von fluorierten aethern.
DE69101775D1 (de) Verfahren zur Herstellung von Wasserstoffperoxid.
DE3869920D1 (de) Verfahren zur herstellung von 1,1-dichlor-1,2,2,2-tetrafluoraethan.
DE3871346D1 (de) Verfahren zur herstellung von nitrilen.
DE3486006D1 (de) Verfahren zur herstellung von halbleiterlasern.
DE3860671D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin.
DE3680454D1 (de) Verfahren zur herstellung von halogenhaltigen (2,2)-paracyclophanen.
DE59007171D1 (de) Verfahren zur herstellung von sclareolid.
DE3785530D1 (de) Verfahren zur herstellung von l-arginin.
DE69021711D1 (de) Verfahren zur Herstellung von optisch aktiven Hydroxylactonen.
DE3585109D1 (de) Verfahren zur herstellung von (+/-)-3a,6,6,9a-tetramethylperhydronaphtho(2,1-b)furan.
DE3680190D1 (de) Verfahren zur herstellung von halbleiterlasern.
DE3381203D1 (de) Verfahren zur herstellung von uridindiphosphat-n-acetylgalactosamin.
DE68916035D1 (de) Verfahren zur selektiven herstellung von 2,6-dialkylnaphthalenen.
DE59105348D1 (de) Verfahren zur Herstellung von 1,4-Alkylendiaminen.
DE69300551D1 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
DE3765129D1 (de) Verfahren zur herstellung von nitrilen.
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
DE69204417D1 (de) Verfahren zur Herstellung von Epoxiden.
DE3578879D1 (de) Verfahren zur herstellung von 1,3-dimethyl-2-imidazolidinon.
DE69210069D1 (de) Verfahren zur Herstellung von 1,3-Dioxolen
DE3874496D1 (de) Verfahren zur herstellung von 4,4'-dibrombiphenyl.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties